HK1218954A1 - 測定急性呼吸窘迫綜合征 相關生物標誌物的方法、監測患者的 的發展和治療的方法 - Google Patents

測定急性呼吸窘迫綜合征 相關生物標誌物的方法、監測患者的 的發展和治療的方法

Info

Publication number
HK1218954A1
HK1218954A1 HK16106861.5A HK16106861A HK1218954A1 HK 1218954 A1 HK1218954 A1 HK 1218954A1 HK 16106861 A HK16106861 A HK 16106861A HK 1218954 A1 HK1218954 A1 HK 1218954A1
Authority
HK
Hong Kong
Prior art keywords
ards
patient
monitor
development
treatment
Prior art date
Application number
HK16106861.5A
Other languages
English (en)
Inventor
Mikael Maksimow
Marko Salmi
Markku Jalkanen
Sirpa Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Publication of HK1218954A1 publication Critical patent/HK1218954A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/125Adult respiratory distress syndrome
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90Plate chromatography, e.g. thin layer or paper chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
HK16106861.5A 2013-02-14 2016-06-15 測定急性呼吸窘迫綜合征 相關生物標誌物的方法、監測患者的 的發展和治療的方法 HK1218954A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20130049 2013-02-14
PCT/FI2014/050051 WO2014125164A1 (en) 2013-02-14 2014-01-22 A method for determining acute respiratory distress syndrome (ards) related biomarkers, a method to monitor the development and treatment of ards in a patient

Publications (1)

Publication Number Publication Date
HK1218954A1 true HK1218954A1 (zh) 2017-03-17

Family

ID=51353514

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16106861.5A HK1218954A1 (zh) 2013-02-14 2016-06-15 測定急性呼吸窘迫綜合征 相關生物標誌物的方法、監測患者的 的發展和治療的方法
HK16107094.2A HK1219130A1 (zh) 2013-02-14 2016-06-21 測定急性呼吸窘迫綜合征 相關生物標誌物的方法、監測患者的 的發展和治療的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16107094.2A HK1219130A1 (zh) 2013-02-14 2016-06-21 測定急性呼吸窘迫綜合征 相關生物標誌物的方法、監測患者的 的發展和治療的方法

Country Status (18)

Country Link
US (1) US10247730B2 (zh)
EP (1) EP2956772B1 (zh)
JP (1) JP6337020B2 (zh)
KR (1) KR102121369B1 (zh)
CN (1) CN105164535B (zh)
AU (1) AU2014217753B2 (zh)
BR (1) BR112015018213B1 (zh)
CA (1) CA2898111C (zh)
DK (1) DK2956772T3 (zh)
ES (1) ES2683854T3 (zh)
HK (2) HK1218954A1 (zh)
HU (1) HUE038959T2 (zh)
LT (1) LT2956772T (zh)
PL (1) PL2956772T3 (zh)
PT (1) PT2956772T (zh)
SI (1) SI2956772T1 (zh)
WO (1) WO2014125164A1 (zh)
ZA (1) ZA201505386B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506889A (ja) 2011-02-18 2014-03-20 ステムディーアール インク. Sirt1発現誘導物質を含む敗血症または敗血症性ショックの予防または治療用組成物
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
WO2015105955A1 (en) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
WO2017171293A1 (ko) 2016-03-31 2017-10-05 (주) 인텍플러스 광산화 증폭을 이용한 고감도 바이오마커 정량 방법
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
WO2018204509A1 (en) * 2017-05-02 2018-11-08 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Predictive factors for acute respiratory distress syndrome
JP2021507561A (ja) 2017-12-14 2021-02-22 フロデザイン ソニックス, インク.Flodesign Sonics, Inc. 音響トランスデューサドライバ及びコントローラ
US20210147570A1 (en) * 2018-04-12 2021-05-20 Bristol-Myers Squibb Company Anticancer combination therapy with cd73 antagonist antibody and pd-1/pd-l1 axis antagonist antibody
WO2021250267A1 (en) * 2020-06-11 2021-12-16 Scailyte Ag A method for early detection of propensity to severe clinical manifestations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190872B1 (en) * 1994-05-06 2001-02-20 Gus J. Slotman Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method
JP2002220343A (ja) * 2001-01-26 2002-08-09 Toray Ind Inc びまん性肺疾患延命剤
WO2003038444A2 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Biomarkers of liver function
US20040072237A1 (en) 2001-12-26 2004-04-15 Barry Schweitzer Use of cytokines secreted by dendritic cells
GB0414798D0 (en) * 2004-07-01 2004-08-04 Paradigm Therapeutics Ltd Receptor
WO2006039819A1 (en) 2004-10-15 2006-04-20 St. Michael's Hospital Markers of lung injury
CN103172739A (zh) * 2005-06-30 2013-06-26 Abbvie公司 Il-12/p40结合蛋白
DE102006046411A1 (de) 2006-09-20 2008-03-27 Eberhard-Karls-Universität Tübingen Universitätsklinikum Arzneimittel zur Prophylaxe oder Behandlung oder Diagnostik von akutem Lungenversagen (ALI)
FI20070795A0 (fi) * 2007-10-24 2007-10-24 Faron Pharmaceuticals Oy Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
WO2011085343A1 (en) * 2010-01-11 2011-07-14 Alexion Pharmaceuticals, Inc Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies

Also Published As

Publication number Publication date
KR20150118107A (ko) 2015-10-21
AU2014217753A1 (en) 2015-07-23
BR112015018213A8 (pt) 2019-11-05
PL2956772T3 (pl) 2018-12-31
EP2956772A4 (en) 2016-09-14
US10247730B2 (en) 2019-04-02
CN105164535A (zh) 2015-12-16
HK1219130A1 (zh) 2017-03-24
PT2956772T (pt) 2018-10-19
CN105164535B (zh) 2018-04-10
WO2014125164A1 (en) 2014-08-21
US20150377885A1 (en) 2015-12-31
ZA201505386B (en) 2021-09-29
JP2016513253A (ja) 2016-05-12
HUE038959T2 (hu) 2018-12-28
DK2956772T3 (en) 2018-08-13
EP2956772A1 (en) 2015-12-23
EP2956772B1 (en) 2018-05-30
CA2898111C (en) 2022-02-15
AU2014217753B2 (en) 2018-07-05
SI2956772T1 (sl) 2018-11-30
LT2956772T (lt) 2018-10-25
ES2683854T3 (es) 2018-09-28
JP6337020B2 (ja) 2018-06-06
CA2898111A1 (en) 2014-08-21
KR102121369B1 (ko) 2020-06-11
BR112015018213B1 (pt) 2022-12-20
BR112015018213A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
HK1219130A1 (zh) 測定急性呼吸窘迫綜合征 相關生物標誌物的方法、監測患者的 的發展和治療的方法
ZA201507560B (en) Device and method for determining the blood oxygen saturation of a subject
IL239822A0 (en) Device and methods for the analysis of inhaled gas
GB201402759D0 (en) A method and apparatus for determining the location of a medical instrument with respect to ultrasound imaging, and a medical instrument to facilitatesuch
EP2976033A4 (en) APPARATUSES, SYSTEMS AND METHODS FOR DETERMINING THE OXYGENATION OF A FABRIC
PL3719659T3 (pl) Sposób, aparat i system do pomiaru opóźnienia w fizycznej jednostce obwodu
HK1208331A1 (zh) 用於確定生理參數的系統、方法和相關設備
GB201312934D0 (en) Respiratory therapy apparatus, sensors and methods
EP2834618A4 (en) DEVICE FOR OPTICAL COHERENCE TOMOGRAPHY AND METHOD FOR OPTICAL COHERENCE TOMOGRAPHY
EP2950711A4 (en) DETECTION, DIAGNOSIS AND MONITORING OF OSTEOPOROSIS BY A PHOTOACOUSTIC PROCESS
GB201316566D0 (en) Apparatus and Method for User Exercise Monitoring
GB201311314D0 (en) Apparatus and method for performing photoacoustic tomography
IL244327B (en) Method and system for measuring breath analyte
EP3005930A4 (en) CATHETER FOR OPTICAL COHERENCE TOMOGRAPHY AND METHOD FOR PRODUCING CATHETER
SG11201501208QA (en) Method and device for quantifying heart rate variability (hrv) coherence
EP2975387A4 (en) DEVICE FOR ANALYZING BLOOD CONDITION, SYSTEM FOR ANALYZING BLOOD CONDITION AND PROGRAM FOR ANALYZING BLOOD CONDITION
SG11201600083YA (en) Method and system for measuring oxyhemoglobin saturation in blood
GB2519400B (en) Apparatus for blood concentration
EP3072450A4 (en) OPTICAL PROBE FOR OPTICAL COHERENCE TOMOGRAPHY AND METHOD FOR MANUFACTURING THE SAME
EP2702958A4 (en) DENTAL TREATMENT DIAGNOSTIC PROCEDURE, METHOD FOR CALCULATING DETERMINATION INDICATORS, PROGRAM THEREFOR AND COMPUTER THEREWITH
GB201312720D0 (en) An apparatus, method and computer program for detecting physiological parameters
GB2509955B (en) Methods, apparatus and computer programs for use in measurement reporting
EP2829230A4 (en) DEVICE FOR DETERMINING THE DEGREE OF AWAKENING, PROGRAM FOR DETERMINING THE DEGREE OF AWAKENING AND METHOD FOR DETERMINING THE DEGREE OF AWAKENING
EP2904431A4 (en) APPARATUS AND METHODS FOR ERROR REDUCTION OF MEASUREMENTS
HK1212999A1 (zh) 用於治療和/或限制糖尿病的發展的方法